aap Implantate AG

Earnings Release • Dec 16, 2008

News Details

Ad-hoc | 16 December 2008 14:22

aap Implantate AG: aap reduces growth expectation for fiscal 2008

aap Implantate AG / Change in Forecast

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

aap Implantate AG, a medical technology company listed on the Frankfurt
stock exchange in the Prime Standard segment, will achieve a growth in
sales, but not of the 20% planned.

The reduction of the sales targets is due to the Biomaterials division
falling well behind its projected sales in the fourth quarter. The main
reasons for this are the significant changes in environmental customers’
order behavior (reduction of inventories) as well as delays in planned
approvals of new products. Fourth-quarter growth expectations of the
Biomaterials division will be below expectations, so aap does not
anticipate a year-on-year improvement on the very strong fourth quarter of
2007 (Q4/2007: sales EUR 6.3 million).

The Trauma & Orthopaedics division has shown in the fiscal 2008 a
significant overall above-average improvement in sales as well as the
result and therefore could continue last year’s growth trend with a
significant double digit sales increase.

The reduced growth expectation for the entire company will have negative
implications on the planned overall company result. That is why aap is
preparing an extensive cost reduction program to offset the reduced growth
expectations in 2008 and achieve a marked result improvement in 2009. In
view of sales developments to date and of one-time effects due to cost
reductions and possible value adjustments, the full-year overall result
will probably not reach its previous years earnings before taxes on income
of EUR 2.4 million.

The company plans to publish interim full year 2008 sales figures during
January 2009.

Contact:
Bei Rückfragen wenden Sie sich bitte an:
aap Implantate AG; Nanette Hüdepohl; Head of Corporate Communications &
Legal Affairs; Lorenzweg 5; D-12099 Berlin
Tel.: ++49/30/750 19 – 133; Fax.: ++49/30/750 19 – 290; n.huedepohl@aap.de

16.12.2008 Financial News transmitted by DGAP

Language: English
Issuer: aap Implantate AG
Lorenzweg 5
12099 Berlin
Deutschland
Phone: +49 (0) 30 75 01 90
Fax: +49 (0) 30 75 01 91 11
E-mail: aap@aap.de
Internet: www.aap.de
ISIN: DE0005066609
WKN: 506660
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Hannover, Düsseldorf, Hamburg, München, Stuttgart

End of News DGAP News-Service

---